Bausch Health Companies (BHC) Goodwill (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Goodwill came in at $9.8 billion in Q2 2026, down 13.32% year-over-year from $11.3 billion in Q2 2025, and little changed quarter-over-quarter from $9.8 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Goodwill (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Goodwill across 18 years of filings, most recently posting $9.8 billion for Q2 2026.
- In Q2 2026, Goodwill fell 13.32% year-over-year to $9.8 billion; the TTM figure through Jun 2026 stood at $9.8 billion (down 13.32% YoY), while the FY2025 annual figure was $11.3 billion, up 1.66% from the prior year.
- Goodwill came in at $9.8 billion for Q2 2026 at Bausch Health Companies, roughly flat from $9.8 billion in the prior quarter.
- In the past five years, Goodwill ranged from a high of $12.4 billion in Q1 2022 to a low of $9.8 billion in Q2 2026.
- Average Goodwill over 5 years is $11.3 billion, with a median of $11.2 billion recorded in 2023.
- Year-over-year, Goodwill increased 1.66% in 2025 and retreated 13.32% in 2026.
- Over 5 years, Goodwill stood at $11.5 billion in 2022, then fell by 3.15% to $11.2 billion in 2023, then fell by 0.86% to $11.1 billion in 2024, then advanced by 1.66% to $11.3 billion in 2025, then fell by 13.11% to $9.8 billion in 2026.
- Per Business Quant data, the three most recent Goodwill figures were $9.8 billion in Q2 2026, $9.8 billion in Q1 2026, and $11.3 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.79 Bn |
| Mar 31, 2026 | 9.81 Bn |
| Dec 31, 2025 | 11.27 Bn |
| Sep 30, 2025 | 11.29 Bn |
| Jun 30, 2025 | 11.30 Bn |
| Mar 31, 2025 | 11.15 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Sep 30, 2024 | 11.17 Bn |
| Jun 30, 2024 | 11.13 Bn |
| Mar 31, 2024 | 11.16 Bn |
| Dec 31, 2023 | 11.18 Bn |
| Sep 30, 2023 | 11.19 Bn |
| Jun 30, 2023 | 11.63 Bn |
| Mar 31, 2023 | 11.58 Bn |
| Dec 31, 2022 | 11.55 Bn |
| Sep 30, 2022 | 12.04 Bn |
| Jun 30, 2022 | 12.27 Bn |
| Mar 31, 2022 | 12.43 Bn |
| Dec 31, 2021 | 12.46 Bn |
| Sep 30, 2021 | 12.48 Bn |